129 related articles for article (PubMed ID: 37551463)
1. [Relationship between
Yang FY; Xu LH; Wang J; Zhang YT; Lin SF; Wang KM; Zhou DH; Fang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):967-972. PubMed ID: 37551463
[TBL] [Abstract][Full Text] [Related]
2. Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity.
Tan Y; Kong Q; Li X; Tang Y; Mai H; Zhen Z; Zhou D; Chen H
Transl Pediatr; 2023 Jan; 12(1):31-45. PubMed ID: 36798930
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the
Guo Q; Sun JL; Li R; Li X
Int J Gen Med; 2024; 17():1221-1231. PubMed ID: 38559593
[TBL] [Abstract][Full Text] [Related]
4. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K
Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
[TBL] [Abstract][Full Text] [Related]
5. The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia.
Shen Y; Wang Z; Zhou F; Jin R
Open Life Sci; 2021; 16(1):1203-1212. PubMed ID: 34761111
[TBL] [Abstract][Full Text] [Related]
6. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN
Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Kantar M; Kosova B; Cetingul N; Gumus S; Toroslu E; Zafer N; Topcuoglu N; Aksoylar S; Cinar M; Tetik A; Eroglu Z
Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036
[TBL] [Abstract][Full Text] [Related]
8. Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia.
Chae H; Kim M; Choi SH; Kim SK; Lee JW; Chung NG; Cho B; Kim Y
J Chemother; 2020 Sep; 32(5):251-259. PubMed ID: 32431230
[TBL] [Abstract][Full Text] [Related]
9. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J
Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084
[TBL] [Abstract][Full Text] [Related]
10. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.
Yang L; Hu X; Xu L
Tumour Biol; 2012 Oct; 33(5):1445-54. PubMed ID: 22528943
[TBL] [Abstract][Full Text] [Related]
11. Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis.
Liu B; Liu G; Liu B; Guo Y; Peng N; Li T
World J Surg Oncol; 2024 Jan; 22(1):19. PubMed ID: 38212758
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic Variants in MTHFR Gene are Significant Predictors of Methotrexate Toxicities in Bangladeshi Patients With Acute Lymphoblastic Leukemia.
Zahra FT; Nahid NA; Islam MR; Al-Mamun MMA; Apu MNH; Nahar Z; Kabir AL; Biswas SK; Ahmed MU; Islam MS; Hasnat A
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e58-e65. PubMed ID: 31884153
[TBL] [Abstract][Full Text] [Related]
13. The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis.
Yao P; He X; Zhang R; Tong R; Xiao H
Hematology; 2019 Dec; 24(1):10-19. PubMed ID: 30024839
[TBL] [Abstract][Full Text] [Related]
14. Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia.
Frikha R; Jemaa MB; Frikha F; Turki I; Elloumi M; Keskes L; Kamoun H; Rebai T
J Oncol Pharm Pract; 2021 Sep; 27(6):1382-1387. PubMed ID: 32865163
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia].
Zheng MM; Yue LJ; Chen XW; Wen FQ; Li CG; Yang CL; Xie C; Ding H
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar; 15(3):201-6. PubMed ID: 23498762
[TBL] [Abstract][Full Text] [Related]
16. Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients.
Lu S; Zhu X; Li W; Chen H; Zhou D; Zhen Z; Sun F; Huang J; Zhu J; Wang J; Zhang Y; Sun X
Front Oncol; 2021; 11():598226. PubMed ID: 33718146
[TBL] [Abstract][Full Text] [Related]
17. Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population.
Liu SG; Li ZG; Cui L; Gao C; Li WJ; Zhao XX
Leuk Lymphoma; 2011 Jun; 52(6):1030-40. PubMed ID: 21534867
[TBL] [Abstract][Full Text] [Related]
18. Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis.
Zhu C; Liu YW; Wang SZ; Li XL; Nie XL; Yu XT; Zhao LB; Wang XL
Pharmacogenomics J; 2018 May; 18(3):450-459. PubMed ID: 28696419
[TBL] [Abstract][Full Text] [Related]
19. [Effect of GSTP1 and MTHFR Gene Polymorphism on Side Effects of HD-MTX in ALL Children].
Li F; Yin DD; Zhou XL; Ma JM; Guo HM; Meng L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):723-728. PubMed ID: 28641625
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience.
Frikha R; Rebai T; Lobna BM; Frikha F; Mdhaffar M; Frikha I; Elloumi M; Bouayed N
J Oncol Pharm Pract; 2019 Jul; 25(5):1182-1186. PubMed ID: 30545275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
